Pfizer says they are working on Omicron specific vaccine if needed.
Pfizer and BioNTech says its preliminary lab tests suggest a third dose of its vaccine is providing strong protection agains the Omicron variant.
With health officials urging people to get a third dose, Pfizer has released a study on whether booster shots of its COVID-19 vaccine may make an important difference.
The company says a booster dose may offer significant protection against the new Omicron variant even though the initial two doses appear significantly less effective.
Pfizer-BioNTech says its already working on creating an Omicron-specific vaccine and could have it ready for March of 2022 if needed.
Province Investing Against Invasive Species
Niagara Driver Charged with Drug Impairment
Welland Man Arrested for Child Porn
28 More Doctors Hired in Niagara
Killed Police Officers Honoured by NRP
Niagara Wineries Shuttle Service Possible
Canal Days Vendors Warned of Scams
Niagara Falls Exploring Hub to Help Homeless